D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 97 Citations 40,744 364 World Ranking 4270 National Ranking 2420
Best female scientists D-index 102 Citations 46,086 462 World Ranking 810 National Ranking 504

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Alzheimer's disease
  • Disease

Mary Sano spends much of her time researching Alzheimer's disease, Dementia, Internal medicine, Psychiatry and Disease. Her study in Alzheimer's disease is interdisciplinary in nature, drawing from both Relative risk, Central nervous system disease, Degenerative disease and Pediatrics. Her studies in Dementia integrate themes in fields like Physical therapy, Neuropsychological test, Cognition and Neurology.

Her research integrates issues of Placebo and Surgery in her study of Internal medicine. Her work in Psychiatry addresses subjects such as Donepezil, which are connected to disciplines such as Hazard ratio, Confidence interval and Vitamin E. Her biological study spans a wide range of topics, including PICALM, Psychosis and Computational biology, Systems biology.

Her most cited work include:

  • A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study (2116 citations)
  • Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment (1478 citations)
  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. (1435 citations)

What are the main themes of her work throughout her whole career to date?

Mary Sano mostly deals with Dementia, Disease, Cognition, Gerontology and Alzheimer's disease. Her research integrates issues of Psychiatry, Physical therapy, Cohort and Risk factor in her study of Dementia. In her research on the topic of Disease, Clinical Dementia Rating is strongly related with Clinical trial.

Her biological study spans a wide range of topics, including Type 2 diabetes, Clinical psychology and Cognitive decline. Her Alzheimer's disease research is within the category of Internal medicine. Her Internal medicine research focuses on subjects like Placebo, which are linked to Randomized controlled trial.

She most often published in these fields:

  • Dementia (40.57%)
  • Disease (35.81%)
  • Cognition (33.33%)

What were the highlights of her more recent work (between 2018-2021)?

  • Dementia (40.57%)
  • Cognition (33.33%)
  • Cognitive decline (17.14%)

In recent papers she was focusing on the following fields of study:

Mary Sano focuses on Dementia, Cognition, Cognitive decline, Disease and Gerontology. The study incorporates disciplines such as Prospective cohort study, Randomized controlled trial and Cohort in addition to Dementia. Her Cognition research is multidisciplinary, incorporating elements of Anesthesia and Clinical psychology.

Her Cognitive decline study also includes fields such as

  • Depression that intertwine with fields like Anxiety and Alzheimer's disease,
  • Episodic memory which is related to area like Categorization. Her work in the fields of Alzheimer's disease, such as Clinical Dementia Rating, intersects with other areas such as Core. Her Gerontology study incorporates themes from Mental health and Cognitive impairment.

Between 2018 and 2021, her most popular works were:

  • Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001 (24 citations)
  • Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure (19 citations)
  • Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure (19 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

Mary Sano mainly focuses on Dementia, Cognitive decline, Cognition, Internal medicine and Prospective cohort study. Her Dementia study is concerned with the larger field of Disease. Her Cognitive decline research focuses on Depression and how it relates to Alzheimer's disease.

Mary Sano interconnects Psychological intervention, Anesthesia, Informed consent and Diabetes risk in the investigation of issues within Cognition. Her research in the fields of Cohort overlaps with other disciplines such as Induced pluripotent stem cell. As part of one scientific family, Mary Sano deals mainly with the area of Prospective cohort study, narrowing it down to issues related to the Incidence, and often Activities of daily living, Pediatrics, Risk factor and Re experiencing.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Mary Sano;Christopher Ernesto;Ronald G. Thomas;Melville R. Klauber.
The New England Journal of Medicine (1997)

3198 Citations

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Ronald C. Petersen;Ronald G. Thomas;Michael Grundman;David Bennett.
The New England Journal of Medicine (2005)

2081 Citations

Common variants at MS4A4/MS4A6E , CD2AP , CD33 and EPHA1 are associated with late-onset Alzheimer's disease

Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)

1580 Citations

Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

Paul S. Aisen;Kimberly A. Schafer;Michael Grundman;Eric Pfeiffer.
JAMA (2003)

1291 Citations

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease.

Douglas Galasko;David Bennett;Mary Sano;Chris Ernesto.
Alzheimer Disease & Associated Disorders (1997)

1230 Citations

Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities.

T K Tatemichi;D W Desmond;Y Stern;M Paik.
Journal of Neurology, Neurosurgery, and Psychiatry (1994)

1079 Citations

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

Michael Grundman;Ronald C. Petersen;Steven H. Ferris;Ronald G. Thomas.
JAMA Neurology (2004)

1054 Citations

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

Devangere P. Devanand;Mary Sano;Mingxin Tang;Stuart Taylor.
Archives of General Psychiatry (1996)

744 Citations

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

Rachelle S Doody;Svetlana I Gavrilova;Mary Sano;Ronald G Thomas.
The Lancet (2008)

644 Citations

Dementia after stroke Baseline frequency, risks, and clinical features in a hospitalized cohort

T. K. Tatemichi;D. W. Desmond;R. Mayeux;M. Paik.
Neurology (1992)

624 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mary Sano

Richard Mayeux

Richard Mayeux

Columbia University

Publications: 250

Yaakov Stern

Yaakov Stern

Columbia University

Publications: 250

Jeffrey L. Cummings

Jeffrey L. Cummings

University of Nevada, Las Vegas

Publications: 185

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 157

David A. Bennett

David A. Bennett

Rush University Medical Center

Publications: 157

John C. Morris

John C. Morris

Washington University in St. Louis

Publications: 143

Bruno Vellas

Bruno Vellas

Federal University of Toulouse Midi-Pyrénées

Publications: 134

Jennifer J. Manly

Jennifer J. Manly

Columbia University

Publications: 134

Paul S. Aisen

Paul S. Aisen

University of Southern California

Publications: 121

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 118

Lon S. Schneider

Lon S. Schneider

University of Southern California

Publications: 109

Serge Gauthier

Serge Gauthier

McGill University

Publications: 107

Bengt Winblad

Bengt Winblad

Karolinska Institute

Publications: 107

Lan Tan

Lan Tan

Qingdao University

Publications: 104

John Hardy

John Hardy

University College London

Publications: 104

Philip L. De Jager

Philip L. De Jager

Columbia University

Publications: 102

Something went wrong. Please try again later.